Intercept Pharmaceuticals, Inc.: capex
| Value | {"amount": 4643000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2014-01-01 – 2014-12-31 |
| Status | current |
| Entity | Intercept Pharmaceuticals, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T12:06:46.156809+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/37f23734-5003-4a1c-aa2c-cb89cbd4a20b
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001144204-16-085037 · Open the official SEC filing →Retrieved: 2026-08-19T12:06:46.156809+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001270073/capex/2014-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/37f23734-5003-4a1c-aa2c-cb89cbd4a20b
History
- supersedes {"amount": 4643171, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} (evidence 0001144204-15-013338)